Non-viral HCC miRNA profiling reveals miR-1972 as a potential positive prognostic marker
Open Access
- 1 December 2025
- journal article
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 15, 100-107
Abstract
Hepatocellular carcinoma (HCC) is the third deadliest cancer worldwide. Its high mortality is primarily attributed to late-stage diagnosis. While mutations in driver genes, such as those encoding β-catenin (CTNNB1), tumor protein p53 (TP53), and telomerase reverse transcriptase promoter (TERTp) are well-documented in the literature, dysregulation of microRNAs (miRNAs), small non-coding RNAs that serve as crucial translational regulators, remains poorly understood. We conducted microRNA profiling by microarrays in 45 paired (tumor and non-tumor adjacent tissue) samples from non-viral HCC patients. We performed clinical correlation, ROC analysis and survival analysis of time to recurrence (TTR), disease-free survival (DFS) and overall survival. We identified 23 significantly dysregulated miRNAs (p ≤ 0.05, fold change ≥2). We investigated their differential expression and its relationship with clinical and pathological variables. Further, we found that miRNA-1972 may serve as an important positive prognostic marker because its high levels were associated with longer TTR and DFS. Significant positive results were obtained in receiver operating characteristic analysis for miR-1972, miR-3651 and miR-486-5p. miRNA-1972 is a strong prognostic marker in non-viral HCC. Dysregulation of several other miRNAs relates to pathological variables such as amount of stroma within tumor, microvascular invasion and micronodularity.Keywords
Funding Information
- National Cancer Research Institute
- Charles University Faculty of Medicine in Pilsen
This publication has 34 references indexed in Scilit:
- Aetiology of liver disease and response to immune checkpoint inhibitors: An updated meta-analysis confirms benefit in those with non-viral liver diseaseJournal of Hepatology, 2023
- Hepatocellular carcinomaThe Lancet, 2022
- Cellular heterogeneity and plasticity in liver cancerSeminars in Cancer Biology, 2022
- Long non‐coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA‐1972 and upregulating LIM and SH3 protein 1IUBMB Life, 2020
- Tumour budding and tumour–stroma ratio in hepatocellular carcinomaBritish Journal of Cancer, 2020
- miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFRCell Death & Disease, 2020
- Goals and targets for personalized therapy for HCCHepatology International, 2019
- MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathwayExperimental Cell Research, 2017
- miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1Biochemical and Biophysical Research Communications, 2017
- Tumor–stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantationSurgery, 2015